News - Boehringer Ingelheim

Filter

Current filters:

Boehringer Ingelheim

Popular Filters

160 to 167 of 167 results

Judge vacates Amylin injunction against Eli Lilly; latter updates Humalog label

09-06-2011

It was a good news day for US drug major Eli Lilly (NYSE: LLY) yesterday, as the firm received approval…

AmylinBoehringer IngelheimDiabetesEli LillyExenatide InjectionHumalogLegallinagliptinNorth AmericaPharmaceuticalRegulation

Investment in oncology drug development remains strong, with 133 firm initiating late-stage trials

03-06-2011

Trials targeting non-small cell lung cancer, breast cancer and multiple hematological cancers are amongst…

Boehringer IngelheimMerck KGaANovartisOncologyPharmaceuticalResearchRoche

Changing the Indian culture in reporting adverse drug reactions

01-06-2011

Adverse drug reactions (ADRs) are the sixth global leading cause of death among hospitalized patients…

Asia-PacificBoehringer IngelheimPharmaceuticalRegulationResearch

Amylin wins first round in squabble with Lilly over diabetes link with Boehringer

27-05-2011

In an initial win for US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN), the US District Court for…

AmylinBoehringer IngelheimDiabetesEli LillyExenatide InjectionLegallinagliptinNorth AmericaPharmaceuticalTradjenta

Amylin sues Eli Lilly, alleging anti-competitive activity

17-05-2011

San Diego, USA-based Amylin Pharmaceuticals (Nasdaq: AMLN) has filed a law suit against drug major Eli…

AmylinBoehringer IngelheimByettaDiabetesEli LillyLegallinagliptinPharmaceuticalTradjenta

US FDA clears Boehringer and Lilly’s diabetes drug Tradjenta

04-05-2011

The US Food and Drug Administration has approved Tradjenta (linagliptin), for use along with diet and…

Boehringer IngelheimDiabetesEli LillylinagliptinNorth AmericaPharmaceuticalRegulationTradjenta

EMA’s CHMP advisory unit decisions include good news for Lilly, Bristol-Myers, Boehringer and Roche

18-04-2011

Following meetings last week of the European Medicines Agency’s Committee for Medicinal Products…

AvastinBoehringer IngelheimBristol-Myers SquibbBydureonEli LillyEuropeNulojixPharmaceuticalPradaxaRegulationRoche

160 to 167 of 167 results

Back to top